Polisano Pharmaceuticals, with a turnover of 4 million lei in 2015, changed its legal form from the limited liability company into a joint-stock company and increased its capital by 26.8 million lei as a result of the four new shareholders participation in the company.
Polisano Pharmaceuticals Ltd, the pharmaceutical products factory based in Sibiu, part of the Vonica family-controlled Polisano group, received a capital injection of 51.6 million lei, according to data recently published in the Official Monitor.
Part of the POLISANO Group - the only group of integrated health services in Romania. The Polisano Pharmaceuticals factory, representing an investment of 67 million euros, has obtained the NAMMD authorization for conducting clinical trials in the field of medicine, on September 9th 2015, which enabled the inauguration of the Bioequivalence Centre, and the conduct of clinical trials.
After the final audit - which ended last week - and getting approvals from the two governments – for which the related dossiers were already submitted – the Polisano pharmaceutical products factory will be the first domestic producer of drugs in Oncology.
Ambassador of Cuba to Bucharest, Nieves Iliana Hernandez Portales ...